tiprankstipranks
Trending News
More News >
Nanobiotix SA (FR:NANO)
:NANO

Nanobiotix (NANO) Stock Statistics & Valuation Metrics

Compare
12 Followers

Total Valuation

Nanobiotix has a market cap or net worth of €195.78M. The enterprise value is €196.91M.
Market Cap€195.78M
Enterprise Value€196.91M

Share Statistics

Nanobiotix has 47,133,327 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding47,133,327
Owned by Insiders
Owned by Institutions

Financial Efficiency

Nanobiotix’s return on equity (ROE) is 1.04 and return on invested capital (ROIC) is -510.92%.
Return on Equity (ROE)1.04
Return on Assets (ROA)-1.01
Return on Invested Capital (ROIC)-510.92%
Return on Capital Employed (ROCE)-8.06
Revenue Per Employee-107.49K
Profits Per Employee-630.85K
Employee Count108
Asset Turnover-0.17
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Nanobiotix is -2.10. Nanobiotix’s PEG ratio is -0.19.
PE Ratio-2.10
PS Ratio0.00
PB Ratio-2.98
Price to Fair Value-2.17
Price to FCF-127.86
Price to Operating Cash Flow-188.81
PEG Ratio-0.19

Income Statement

In the last 12 months, Nanobiotix had revenue of -11.61M and earned -68.13M in profits. Earnings per share was -1.44.
Revenue-11.61M
Gross Profit-11.61M
Operating Income-68.39M
Pretax Income-68.03M
Net Income-68.13M
EBITDA-61.62M
Earnings Per Share (EPS)-1.44

Cash Flow

In the last 12 months, operating cash flow was -19.55M and capital expenditures -846.00K, giving a free cash flow of -20.40M billion.
Operating Cash Flow-19.55M
Free Cash Flow-20.40M
Free Cash Flow per Share-0.43

Dividends & Yields

Nanobiotix pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.44
52-Week Price Change-14.51%
50-Day Moving Average3.27
200-Day Moving Average3.61
Relative Strength Index (RSI)75.79
Average Volume (3m)131.03K

Important Dates

Nanobiotix upcoming earnings date is Sep 4, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateSep 4, 2025
Ex-Dividend Date

Financial Position

Nanobiotix as a current ratio of 1.04, with Debt / Equity ratio of -77.47%
Current Ratio1.04
Quick Ratio1.04
Debt to Market Cap0.33
Net Debt to EBITDA-0.02
Interest Coverage Ratio-8.46

Taxes

In the past 12 months, Nanobiotix has paid 101.00K in taxes.
Income Tax101.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Nanobiotix EV to EBITDA ratio is -2.34, with an EV/FCF ratio of -7.05.
EV to Sales-12.40
EV to EBITDA-2.34
EV to Free Cash Flow-7.05
EV to Operating Cash Flow-7.36

Balance Sheet

Nanobiotix has €49.74M in cash and marketable securities with €50.90M in debt, giving a net cash position of €1.17M billion.
Cash & Marketable Securities€49.74M
Total Debt€50.90M
Net Cash€1.17M
Net Cash Per Share€0.02
Tangible Book Value Per Share-€1.39

Margins

Gross margin is 106.77%, with operating margin of 589.13%, and net profit margin of 586.89%.
Gross Margin106.77%
Operating Margin589.13%
Pretax Margin586.02%
Net Profit Margin586.89%
EBITDA Margin530.83%
EBIT Margin516.37%

Analyst Forecast

The average price target for Nanobiotix is €13.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€13.50
Price Target Upside229.27% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast56.18%

Scores

Smart ScoreN/A
AI Score57
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis